Aug 18, 2019 1:41 AM
BACK TO TOP
KSE 100
28,764.63
-664.44
(-2.26%)
KSE ALL
21,397.34
-370.35
(-1.70%)
KSE 30
13,406.78
-386.39
(-2.80%)
KMI 30
44,929.44
-1426.99
(-3.08%)
KMI ALL
13,453.11
-311.50
(-2.26%)
GlaxoSmithKline Consumer Healthcare
PHARMACEUTICALS
Rs.167.00
2.90
(1.77%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Aug 16, 2019 4:31 PM
REG
FUT
ODL
Open
170.00
High
170.00
Low
165.00
Volume
600
CIRCUIT BREAKER
155.90 — 172.30
DAY RANGE
165.00 — 170.00
52-WEEK RANGE
161.00 — 429.98
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
164.10
VAR
14.85
HAIRCUT
19.25
P/E Ratio (TTM)
20.10
1-Year Change *
-60.43%
YTD Change *
-37.31%
Open
156.04
High
165.00
Low
155.95
Close
165.00
Change
0.55%
LDCP
164.10
Volume
69
Total Trades
8
CIRCUIT BREAKER
155.90 — 172.30
DAY RANGE
155.95 — 165.00
Ask Price
165.00
Ask Volume
36
Bid Price
155.95
Bid Volume
57
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Consumer Healthcare Pakistan Limited was incorporated in Pakistan as a public unlisted company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company is a subsidiary of GlaxoSmithKline Consumer Healthcare B.V. The ultimate parent of the Company is GlaxoSmithKline plc, UK. The Company is engaged in manufacturing, marketing and sale of consumer healthcare products.

KEY PEOPLE
Mr Sohail MatinCEO
Ms Mashal MohammadCompany Secretary
ADDRESS

35 – Dockyard Road, West Wharf, Karachi – 74000

WEBSITE

www.pk-consumerhealthcare.gsk.com

REGISTRAR

Central Depository Company of Pakistan Limited

AUDITOR

Deloitte Yousuf Adil Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
19,548,102.84
Shares
117,054,508
Free Float
15,487,097
Free Float
13.23%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2019Transmission of Quarterly Report for the Period Ended 31 March 2019 View   PDF
Apr 24, 2019Financial Results for the Quarter Ended 31 March 2019 View   PDF
Apr 2, 2019Transmission of Annual Report for the Year Ended 31 December 2018 View   PDF
Oct 30, 2018Transmission of Quarterly Report for the Period Ended 30 September 2018 View   PDF
Oct 30, 2018Financial Results for the Quarter Ended 30 September 2018 View   PDF
Aug 30, 2018 Transmission of Quarterly Report for the Period Ended June 30, 2018 View   PDF
Aug 24, 2018Financial Results for the Quarter Ended - 30 June 2018 View   PDF
Aug 24, 2018Financial Results for the Quarter Ended - 30 June 2018 View   PDF
Apr 27, 2018Financial Results for the Quarter Ended March 2018 View   PDF
Jan 29, 2018Financial Results for the Year Ended 31.12.2017 View   PDF
DateTitleDocument
Jun 21, 2019Board Meeting Other than Financial Results View   PDF
Jun 14, 2019Board Meeting Other than Financial Results View   PDF
Apr 23, 2019Meeting in Progress - Q1-2019 - Board Meeting - 23 April 2019 View   PDF
Apr 2, 2019Notice of Annual General Meeting 2019-04-23 View   PDF
Mar 11, 2019Board Meeting - Q4-2018 View   PDF
Oct 29, 2018Meeting in Progress View   PDF
Oct 23, 2018Board Meeting View   PDF
Sep 28, 2018 Notice of Extraordinary General Meeting View   PDF
Aug 13, 2018Board Meeting View   PDF
Aug 6, 2018GSK Consumer Healthcare Pakistan Limited Board of Directors Meeting - Postponed View   PDF
DateTitleDocument
Aug 2, 2019Material Information View   PDF
May 14, 2019Credit of Final Cash Dividend View   PDF
May 13, 2019Pre-Publication of Notice of Dividend Credit View   PDF
Apr 16, 2019Notice of Election of Directors View   PDF
Apr 16, 2019GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited PDF
Apr 15, 2019Notice of Election - Transmitted Prior to Publication View   PDF
Apr 1, 2019Notice of AGM - Transmitted Prior to Publication View   PDF
Mar 18, 2019GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited PDF
Feb 1, 2019GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited PDF
Jan 21, 2019Material Information Increase of Paid Up Capital and Shareholding View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2018201720162015
Sales14,875,2688,298,1425,375,805
Profit after Taxation1,074,553706,815545,467
EPS9.187.397.60
Q1 2019Q3 2018Q2 2018Q1 2018
Sales3,872,8712,042,8801,808,0543,628,148
Profit after Taxation167,315150,19897,204268,741
EPS1.431.571.012.30
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

201820172016
Gross Profit Margin (%)29.1837.3728.07
Net Profit Margin (%)7.228.5210.15
EPS Growth (%)24.22(2.76)
PEG1.20(15.75)

Payouts

DateFinancial ResultsDetailsBook Closure
March 18, 2019 5:17 PM31/12/2018(YR) 50%(F) (D) 18/04/2019 - 23/04/2019
January 29, 2018 3:23 PM31/12/2017(YR) 50% (D) 23/03/2018 - 29/03/2018

Financial Reports